The present description relates to compounds and forms and pharmaceutical compositions thereof and methods for use thereof to treat or ameliorate bacterial infections caused by wild-type and multi-drug resistant Gram-negative and Gram-positive pathogens.
GOUZOULES F. H.; WHITNEY R. A., J. ORG. CHEM., 51,(1986) N 11, 2024-2030
作者:GOUZOULES F. H.、 WHITNEY R. A.
DOI:——
日期:——
COMPOSITION OF MATTER
申请人:University of Louisiana at Lafayette
公开号:US20170361310A1
公开(公告)日:2017-12-21
The method relates to the field of asymmetric allylic amination and comprises preparing a chiral N-substituted allylic amine compound from the corresponding allylic substrates and substituted hydroxylamines, in the presence of a catalyst, said catalyst comprising copper compounds and a chiral ligand. Examples of chiral amine compounds which can be made using the method include Vigabatrin, Ezetimibe Terbinafine, Naftifine 3-methylmorphine, Sertraline, Cinacalcet, Mefloquine hydrochloride, and Rivastigmine. There are over 20,000 known bioactive molecules with chiral N-substituted allylic amine substructure. The method may also be used to produce non-natural chiral β-aminoacid esters, a sub-class of chiral N-substituted allylic amine compounds. Examples of β-aminoacid ester which can be produced by the disclosed method, include, but are not limited to, N-(2-methylpent-1-en-3-yl)benzenamine and Ethyl 2-methylene-3-(phenylamino)butanoate. Further, the products of the method described herein can be used to produce chiral heterocycles and bioactive molecules or materials. A novel chiral copper-ligand nitrosoarene complex is also set forth.
ALKALINE AGENT FOR LIGHTENING HAIR CONTAINING OXIDANTS AND SPECIAL CARBOXYLIC ACID ESTERS
申请人:Henkel AG & Co. KGaA
公开号:US20180140523A1
公开(公告)日:2018-05-24
The subject matter of the present disclosure includes agents for lightening keratin fibers, more particularly human hair, containing in a cosmetic carrier:
(a) at least one carboxylic acid ester of the formula (I)
(b) at least one peroxide compound, and
(c) water,
wherein the agent has a pH value in the range of from about 7.5 to about 12.5.
A further subject matter of the present disclosure includes a kit-of-parts in which the aforementioned components exist packed separately in two agents (A) and (B).